Literature DB >> 11752512

Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease.

T Fujii1, T Nojima, H Yasuoka, S Satoh, K Nakamura, M Kuwana, A Suwa, M Hirakata, T Mimori.   

Abstract

OBJECTIVE: To determine cytokines and MHC class II alleles in Japanese patients with adult Still's disease (ASD) and clarify the association between those profiles and chronic articular disease.
METHODS: Of 35 patients with ASD (13 men, 22 women, mean age at onset 34.0 yr), 17 (49%) had chronic arthritis (>6 months, chronic articular ASD) and 18 (51%) lacked chronic arthritis (systemic ASD). Cytokines and cytokine receptors in sera were measured by ELISA. Correlations of each cytokine with disease activity or C-reactive protein (CRP) were determined. MHC class II alleles were examined by polymerase chain reaction methods.
RESULTS: In chronic articular ASD, female gender was more frequent and liver dysfunction and myalgia were rarer than in systemic ASD. In active disease, the white blood cell count was lower, but total IgG was greater in patients with chronic articular ASD than in those with systemic ASD. Tumour necrosis factor (TNF) alpha, soluble TNF receptor 2 and interleukin (IL)-18 were increased in both types of ASD, even in remission. Soluble IL-2 receptors, IL-4 and IL-18 levels were correlated with disease activity or CRP value only in chronic articular ASD. Interferon gamma and IL-8 remained increased only in chronic articular ASD, even when disease activity, including IL-6 and CRP, was low. DRB1*1501 (DR2) and DRB1*1201 (DR5) alleles were more frequent in chronic articular than in systemic ASD, whereas DQB1*0602 (DQ1) was frequently observed in both types of ASD.
CONCLUSION: The present study suggests that ASD with chronic articular disease has distinct clinical, cytokine and immunogenetic profiles.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11752512     DOI: 10.1093/rheumatology/40.12.1398

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  37 in total

Review 1.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

Review 2.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

3.  Cutaneous manifestations associated with adult-onset Still's disease: important diagnostic values.

Authors:  Toshiyuki Yamamoto
Journal:  Rheumatol Int       Date:  2011-12-25       Impact factor: 2.631

4.  Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.

Authors:  Tsuyoshi Kasama; Hidekazu Furuya; Ryo Yanai; Kumiko Ohtsuka; Ryo Takahashi; Nobuyuki Yajima; Yusuke Miwa; Kazuo Kobayashi
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

5.  Glucocorticoid and cyclosporine refractory adult onset Still's disease successfully treated with tocilizumab.

Authors:  Kazuko Matsumoto; Takao Nagashima; Shino Takatori; Yuta Kawahara; Masaki Yagi; Masahiro Iwamoto; Hitoaki Okazaki; Seiji Minota
Journal:  Clin Rheumatol       Date:  2009-01-30       Impact factor: 2.980

6.  Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis.

Authors:  Jeffrey H Ruth; Christy C Park; M Asif Amin; Charles Lesch; Hubert Marotte; Shiva Shahrara; Alisa E Koch
Journal:  Arthritis Res Ther       Date:  2010-06-16       Impact factor: 5.156

7.  Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients.

Authors:  Alexander Kokkinos; Alexios Iliopoulos; Paraskevi Greka; Anna Efthymiou; Nicholas Katsilambros; Petros P Sfikakis
Journal:  Clin Rheumatol       Date:  2003-11-15       Impact factor: 2.980

8.  Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.

Authors:  D Y Chen; J L Lan; F J Lin; T Y Hsieh; M C Wen
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 9.  Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Authors:  Apostolos Kontzias; Petros Efthimiou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.

Authors:  Yasuhiro Shimojima; Takanori Ichikawa; Dai Kishida; Ryota Takamatsu; Yoshiki Sekijima
Journal:  Clin Exp Immunol       Date:  2021-08-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.